Sacbitol/valsartan in post-exacerbation heart failure patients with mildly reduced or preserved LVEF: the PARAGLIDE-HF study

Sacbitol/valsartan in post-exacerbation heart failure patients with mildly reduced or preserved LVEF: the PARAGLIDE-HF study

The PARAGLIDE-HF study showed that in patients with stable LVEF >40% after a heart failure exacerbation, sacubitril/valsartan significantly reduced NT-proBNP levels and caused fewer cardiovascular events compared with valsartan alone. Dr. by Robert J. Mentz, Duke Clinical Research Institute, and colleagues reported in the online edition of the Journal of the American College of Cardiology.

In the PARAGLIDE-HF study, 466 patients with LVEF >40% who were within 30 days of heart failure h...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Learn more about TCROSS NEWS Global
This website is automatically translated using Google Translate.

Recommendations

Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I Trial
Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I Trial
JACC
PCI of Native Coronary Artery vs Saphenous Vein Graft in Patients With SVG Stenosis After CABG: The PROCTOR Trial
PCI of Native Coronary Artery vs Saphenous Vein Graft in Patients With SVG Stenosis After CABG: The PROCTOR Trial
JACC
Routine Coronary CT Angiography vs Standard Care for Follow-Up After LM-PCI: The PULSE Trial
Routine Coronary CT Angiography vs Standard Care for Follow-Up After LM-PCI: The PULSE Trial
JACC
Trajectories of Angina After Initial Invasive vs Conservative Strategy for Chronic Coronary Disease: A Secondary Analysis of the ISCHEMIA Trial
Trajectories of Angina After Initial Invasive vs Conservative Strategy for Chronic Coronary Disease: A Secondary Analysis of the ISCHEMIA Trial
JACC
PICK UP
Challenging Healthcare Marketing Costs toward Achieving Universal Health Coverage
Special
InsighTCROSS
Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I Trial
JACC
Drug-Coated Balloon Angioplasty vs Up-Front Stenting for De Novo CAD: 3-Year Follow-Up of REC-CAGEFREE I Trial
FFR or 3D-QCA Based Vessel-FFR guided revascularization: the FAST III Trial
ACC.26
FFR or 3D-QCA Based Vessel-FFR guided revascularization: the FAST III Trial
Left Ventricular Unloading With Impella in High-Risk PCI: The CHIP-BCIS3 Trial
ACC
Left Ventricular Unloading With Impella in High-Risk PCI: The CHIP-BCIS3 Trial
IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial
ACC.26
IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial